Literature DB >> 15675552

Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India.

T Santha1, R Garg, R Subramani, V Chandrasekaran, N Selvakumar, R S Sisodia, M Perumal, S K Sinha, R J Singh, R Chavan, F Ali, S K Sarma, K M Sharma, R D Jagtap, T R Frieden, L Fabio, P R Narayanan.   

Abstract

SETTING: Governmental health facilities in six districts of India.
OBJECTIVE: To estimate the prevalence of cough and to compare the detection of smear-positive tuberculosis (TB) among out-patients with cough of > or =2 or > or =3 weeks.
DESIGN: Trained health workers questioned each out-patient for presence of cough. Those with cough > or =2 weeks underwent sputum microscopy.
RESULTS: Of 55561 out-patients interviewed, 2210 (4%) had cough > or =2 weeks, of whom 267 had sputum-positive TB, compared to 182/1370 with cough > or =3 weeks. The 31% who did not spontaneously complain of cough were less likely to be sputum-positive than those who did (45/680 [7%] vs. 222/1530 [15%], P < 0.001), but they accounted for 45/267 smear-positive cases. Using cough > or =2 weeks as the screening criterion, the estimated number of smears performed per day at each primary and secondary health care facility was respectively 8 and 19, compared to 5 and 12 using cough > or =3 weeks.
CONCLUSION: The detection of smear-positive TB cases can be substantially improved by actively eliciting history of cough from all out-patients, and by changing the screening criterion for performing sputum microscopy among out-patients from cough > or =3 weeks to > or =2 weeks. Before implementing this change nationally, its programmatic feasibility should be assessed.

Entities:  

Mesh:

Year:  2005        PMID: 15675552

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

Review 1.  Active case finding of tuberculosis: historical perspective and future prospects.

Authors:  J E Golub; C I Mohan; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

2.  Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, South India.

Authors:  B C Prakash; K S Ravish; B Prabhakar; T S Ranganath; B Naik; S Satyanarayana; P Isaakidis; A M V Kumar
Journal:  Public Health Action       Date:  2013-11-04

Review 3.  Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.

Authors:  Anja Van't Hoog; Kerri Viney; Olivia Biermann; Bada Yang; Mariska Mg Leeflang; Miranda W Langendam
Journal:  Cochrane Database Syst Rev       Date:  2022-03-23

Review 4.  Screening strategies for active tuberculosis: focus on cost-effectiveness.

Authors:  Claudia Caroline Dobler
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-30

5.  Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?

Authors:  Victor Abiola Adepoju; Olanrewaju Oladimeji; C Robert Horsburgh
Journal:  Healthcare (Basel)       Date:  2022-07-12

Review 6.  Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.

Authors:  Stephen K Field; Patricio Escalante; Dina A Fisher; Belinda Ireland; Richard S Irwin
Journal:  Chest       Date:  2017-11-28       Impact factor: 9.410

7.  Tuberculosis management practices by private practitioners in Andhra Pradesh, India.

Authors:  Shanta Achanta; Jyoti Jaju; Ajay M V Kumar; Sharath Burugina Nagaraja; Srinivas Rao Motta Shamrao; Sasidhar Kumar Bandi; Ashok Kumar; Srinath Satyanarayana; Anthony David Harries; Sreenivas Achutan Nair; Puneet K Dewan
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

8.  An evaluation of systematic tuberculosis screening at private facilities in Karachi, Pakistan.

Authors:  Jacob Creswell; Saira Khowaja; Andrew Codlin; Rabia Hashmi; Erum Rasheed; Mubashir Khan; Irfan Durab; Christina Mergenthaler; Owais Hussain; Faisal Khan; Aamir J Khan
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.